The gut microbiota plays an important role in controlling atherosclerosis progression to
support the link between the gut and coronary heart disease. Recent studies have shown …

Atherosclerosis is a leading cause of cardiovascular disease and mortality worldwide.
Alterations in the gut microbiota composition, known as gut dysbiosis, have been shown to …

Background Coronary artery disease (CAD) is associated with gut microbiota alterations in
different populations. Gut microbe-derived metabolites have been proposed as markers of …

Infections have been linked to the development of cardiovascular disease and
atherosclerosis. Findings from the past decade have identified microbial ecosystems …

Gut microbiota and its metabolites such as short chain fatty acids (SCFA),
lipopolysaccharides (LPS), and trimethylamine-N-oxide (TMAO) impact cardiovascular …

Over the past few decades, the treatment of atherosclerotic cardiovascular disease has
mainly been through an LDL lowering strategy and treatments targeting other traditional risk …

Atherosclerosis is considered a chronic inflammatory disease and an intervention targeting
the inflammatory process could be a new therapeutic strategy for preventing atherosclerotic …

Background: Accumulating evidence has shown that disorders in the gut microbiota and
derived metabolites affect the development of atherosclerotic cardiovascular disease …

Atherosclerosis remains the leading cause of death worldwide. Lifestyle modification,
including diet and exercise, is recommended to be the primary prevention strategy for …

Emerging data have demonstrated a strong association between the gut microbiota and the
development of cardiovascular disease (CVD) risk factors such as atherosclerosis …